TOE Study: Treatment and Gait Analysis fOllowing an Excised Lesser Toe

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-105
SponsorUniversity of Huddersfield

About this trial

Summary of study

The study will examine patients with Diabetes Mellitus (DM) who have had a lesser toe amputations (LTA) (toes 2nd3rd,4th or 5th). It is currently not understood how this affects the way patients walk and foot function. No previous studies have been undertaken to examine this and its potential for causing further ulceration risk.

This study is a feasibility study. It is designed to see if it is possible to undertake a large, randomised trial. It will explore how participants are recruited, kept in the study and how easy it is to follow the study protocol.

Aim of the study

Establish the feasibility of a corresponding full scale investigation into to the effectiveness of a toe divider made from Otoform for patients with DM following an LTA.

Study Design

1. Participants will be recruited from Mid Yorkshire NHS teaching Hospital. 2. Participants will be randomised to receive either standard care or an otoform toe divider. 3. Participants age, gender, medical history, medication and blood sugar levels will be recorded. 4. Vascular and neurological assessments, foot posture and toe deformities will be undertaken and recorded. 5. All participants will have pressures measured on the plantar aspects of both feet. 6. Follow up visits will be arranged every 6 weeks for12 months for all participants to monitor foot health and changes in walking pattern and pressure redistribution. 7. If an ulceration or other foot complication occurs, the participants will be removed from the study and appropriate treatment given (the rescue arm of the study).

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Participants over the age of 18.

Participants with DM and a lesser toe amputation.

Participants who wish to take part and provide informed written consent

Participants who are mobile (including those who use walking aids).

Disqualifiers

Participants under the age of 18.

Participants who do not have DM.

Participants who have active ulcerations or surgical sites.

Participants who had had a 1st toe and/or ray amputation.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Otoform toe divider

    Device

    Otoform is a moldable silicone used to make a toe divider.

Treatment groups

30 Participants
are divided into 2 treatment groups
Group A: Study ArmExperimental treatment 1 intervention
Group B: Control ArmNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Acceptibility of wearing a toe divider

theoretical frame work of acceptability questionnaire

Time frame
From enrollment and then every 6 weeks for 52 weeks.

Secondary outcomes

1

Peak Pressure

Peak pressure and where the points of peak pressure are located.

Time frame
From enrollment and then every 6 weeks for 52 weeks.
2

Pressure time integral

Time spent on a certain point of the foot and for how long

Time frame
From enrollment and then every 6 weeks for 52 weeks.
3

Contact Area

Area of the foot that is in contact with the ground

Time frame
From enrollment and then every 6 weeks for 52 weeks.
4

Foot Posture Index

The foot posture index will be used to measure foot posture

Time frame
From enrollment and then every 6 weeks for 52 weeks.

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: